Afinitor Related Clinical Trials
Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Recruiting]
RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer [Recruiting]
Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia [Recruiting]
Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer [Recruiting]
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity [Recruiting]
Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC [Recruiting]
Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal [Recruiting]
Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma [Recruiting]
A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis [Recruiting]
RAD001 for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas [Recruiting]
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) [Recruiting]
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies [Recruiting]
A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer [Recruiting]
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis [Recruiting]
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer [Recruiting]
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer [Recruiting]
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer [Recruiting]
Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma [Recruiting]
Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma [Recruiting]
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 [Not yet recruiting]
Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer [Recruiting]
Dose Finding Study of RAD001 (Everolimus, Afinitor�) in Combination With BEZ235 in Patients With Advanced Solid Tumors [Recruiting]
Study of RAD001 (Everolimus) for Children With NF1 and Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas [Recruiting]
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer [Recruiting]
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) [Recruiting]
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) [Recruiting]
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Recruiting]
Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane [Not yet recruiting]
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers [Recruiting]
Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia [Recruiting]
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex [Not yet recruiting]
STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma [Not yet recruiting]
Anakinra or Denosumab and Everolimus in Advanced Cancer [Recruiting]
Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) [Recruiting]
Erlotinib and Temsirolimus for Solid Tumors [Recruiting]
Sirolimus as Therapeutic Approach to Uveitis [Recruiting]
Sirolimus for Autoimmune Disease of Blood Cells [Recruiting]
A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer [Recruiting]
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer [Recruiting]
Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients [Recruiting]
Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer [Not yet recruiting]
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer [Recruiting]
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients [Recruiting]
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia [Recruiting]
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma [Recruiting]
Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up [Not yet recruiting]
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia [Recruiting]
Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma [Recruiting]
RAD001 Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-Line Treatment [Recruiting]
Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Recruiting]
|
